IL-1 receptor antagonist gene as a predictive biomarker of ...

MorphaBond® ER (morphine extended-release) is an opioid agonist that is Food and Drug Administration (FDA)-approved for the management of pain that is severe enough to require daily, around-the-clock, long-term opioid treatment, and for which alternative treatment options are inadequate. This agent, like other long-acting opioids, should be ... ................
................